2005 on Hong Kong Stock Exchange

Lijun International Pharmaceutical (Holding) Co. Ltd.

Hong Kong pharmaceutical company

Lijun International Pharmaceutical (Holding) Co., Limited (simplified Chinese: 利君国际医药(控股)有限公司; traditional Chinese: 利君國際醫藥(控股)有限公司) (SEHK: 2005) is a Wanchai, Hong Kong–based investment holding company with two pharmaceutical business segments:2 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

2004Founded1

Compare with another stock.

  • Ticker2005 on Hong Kong Stock Exchange1
  • Industrypharmaceutical industry1

Lijun International Pharmaceutical (Holding) Co., Limited (simplified Chinese: 利君国际医药(控股)有限公司; traditional Chinese: 利君國際醫藥(控股)有限公司) (SEHK: 2005) is a Wanchai, Hong Kong–based investment holding company with two pharmaceutical business segments:2

Products and brands

Business segments

manufacturing and selling of intravenous infusion solution

manufacturing and selling of antibiotics and others

The Group was listed on Hong Kong Stock Exchange in December 2005 (stock code: 2005).

The Group is engaged in the research, development, manufacturing and selling of a wide range of finished medicines and bulk pharmaceutical products to hospitals and distributors, including antibiotics, intravenous infusion solution, non-antibiotics finished products, bulk pharmaceuticals and health care product.

Read the full text

Subsidiaries

The Company’s subsidiaries include:

New Orient Limited (New Orient) in Hong Kong

Shijiazhuang No. 4 Pharmaceutical Co., Limited, intravenous infusion solution manufacturer in Hebei Province (acquired in June 2007)

Xi’an Lijun Pharmaceutical Co., Limited (Xi’an Lijun), engaged in manufacturing pharmaceuticals in Shaanxi Province

Shenzhen Lijun Pharmaceutical Co., Limited, engaged in manufacturing pharmaceuticals in Guangdong Province.

The Company is the largest domestic manufacturer of macrolide antibiotics, with a leading position for its intravenous infusion solution products in high-end hospital market.

Facing more merger and acquisition opportunities from medical reform in China, the Group is positioned for continuous mergers and acquisitions to promote its growth.

From Wikipedia’s article on Lijun International Pharmaceutical (Holding) Co. Ltd., shared under CC BY-SA 4.0.3

Timeline

  1. Dec 20, 2005Went public Listed on Hong Kong Stock Exchange1
  2. 2004Founded Founded1